RecruitingPhase 3NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Columbus, OH · Dayton, OH · Shaker Heights, OH · +145 more sites